DE VERNEUIL VANINA (EVP, General Counsel, Corp Sec) sold 13.0% of their position (16.82K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $164.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/26/2026ACC: 0001628280-26-012393
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
-16.82K
Net shares
Net seller
$164.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
16.82K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.12K
Price / share
$9.53
Trade value
$29.71K
% of position
2.4%
2/24/2026
129.80K→126.68K
Common Stock
Direct
Shares
−13.70K
Price / share
$9.82
Trade value
$134.53K
% of position
10.8%
2/25/2026
126.68K→112.98K
Total
Net shares
−16.82K
Net value
-$164.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | S · Sale | −3.12K | $9.53 | $29.71K | 2.4% | 129.80K | 126.68K |
| Common Stock Direct | 2/25/2026 | S · Sale | −13.70K | $9.82 | $134.53K | 10.8% | 126.68K | 112.98K |
| Total | −16.82K | -$164.25K | ||||||
Derivative Transactions0
No derivative transactions reported